Oscar Health Inc. (OSCR)

Oscar Health (OSCR 0.98%) reported a jump in its costs to serve customers, bringing down its profitability.

Oscar Health Inc. OSCR is trading lower on Wednesday, with no apparent news to explain the move. Year-to-date, the stock has gained roughly 15%.

Oscar Health is deeply undervalued but faces high short-term uncertainty due to ACA-specific risks and sector-wide negative catalysts. The expiration of ACA subsidies, adverse selection, and new legis...

Health insurers are experiencing sharp declines in stock prices, which are likely bottoming out. Despite the downturn, it is worth bottom fishing for quality companies like Oscar Healthcare. Oscar Hea...

NEW YORK & DES MOINES, Iowa--(BUSINESS WIRE)--Oscar Health, Inc. (NYSE: OSCR), a leading healthcare technology company in the individual market, and Hy-Vee, Inc., America's No. 1 grocery store based i...

Oscar's Q2 revenue rose 29% YoY to $2.86 billion, with membership growing 28% to over 2 million. The reported 91.1% MLR was distorted by a $692 million retroactive risk adjustment; normalized MLR was ...

In this video, I will review Oscar's (OSCR 5.72%) earnings report and explain why I will be increasing my position. Watch the short video to learn more, consider subscribing, and click the special off...

Oscar Health, Inc. (NYSE:OSCR ) Q2 2025 Earnings Conference Call August 6, 2025 8:00 AM ET Company Participants Chris Potochar - Vice President of Treasury & Investor Relations Mark Thomas Bertolini -...

Oscar Health (OSCR) Q2 Revenue Rises 29%

Oscar Health, Inc. (OSCR) came out with a quarterly loss of $0.89 per share versus the Zacks Consensus Estimate of a loss of $0.9. This compares to earnings of $0.2 per share a year ago.